Results 1 to 10 of about 8,569 (263)

Dynamic effects of China's national volume-based procurement on generic drug consistency evaluation: An interrupted time series analysis. [PDF]

PLoS ONE
ObjectivesChina's national volume-based procurement (NVBP) policy uniquely requires the generic drug consistency evaluation (GCE) for generic drugs on the purchase list.
Xianli Ge, Xiaodong Liu, Weiyu Tian, Jing Peng, Mingyue Zhao, Yu Fang   +5 more
doaj   +2 more sources

Changes in prescription patterns and drug costs following the launch of generic pemetrexed products: a retrospective study in Japan [PDF]

Journal of Pharmaceutical Health Care and Sciences
Background Pemetrexed (PEM) is an antimetabolite antineoplastic agent that has been available in generic form in Japan since June 2021. As a hazardous drug (HD), the use of a closed-system transfer device (CSTD) is recommended.
Toshikazu Ichie, Daisuke Suzuki, Shuji Yamashita, Kunio Naruse, Hideki Hayashi   +4 more
doaj   +2 more sources

When Do Generics Feel Justifiable? A Registered Report Bridging Key Theories [PDF]

Journal of Cognition
Bare plural generics (‘generics’ for short) attribute a feature to members of a category without specifying how many actually possess the feature (e.g., ‘Belgians love fries’).
Felix Hermans, Walter Schaeken, Susanne Bruckmüller, Vera Hoorens   +3 more
doaj   +2 more sources

Generics and Alternatives

Frontiers in Psychology, 2020
In this paper we argue that for the (probabilistic) interpretation of generic sentences of the form “Gs are f,” three types of alternatives play a role: (i) alternative features of f, (ii) alternative groups, or kinds, of G, and (iii) alternative causal ...
Robert Van Rooij, Arnold Kochari, Katrin Schulz   +2 more
exaly   +3 more sources

Comparative analysis of safety and efficacy between brand and generic lamotrigine products in the Saudi market [PDF]

BMC Pharmacology and Toxicology
Background Epilepsy is one of the most chronic neurological disorders worldwide. In 2023, the World Health Organization (WHO) estimates that approximately 50 million individuals globally would be affected by epilepsy.
Haya Alotaibi, Sarah Sulaiman Alenazi, Sarah Alrubia, Maria Arafah, Nourah Alzoman, Aliyah Almomen   +5 more
doaj   +2 more sources

Role of Lactobacillus reuteri DSM 17938 on Crying Time Reduction in Infantile Colic and Its Impact on Maternal Depression: A Real-Life Clinic-Based Study

Clinics and Practice, 2022
Background: Infantile colic is characterized by prolonged periods of inconsolable, incessant crying and persistent fussing in an otherwise healthy infant. It is a self-limiting condition, but causes significant stress to mothers. AIM: To observe the role
Arun Wadhwa, Dhanasekhar Kesavelu, Kishore Kumar, Pallab Chatterjee, Pramod Jog, Sarath Gopalan, Rudra Paul, Krishna Chaitanya Veligandla, Suyog Mehta, Amey Mane, Sucheta Pandit, Rahul Rathod, Sushma Jayan, Monjori Mitra   +13 more
doaj   +1 more source

Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?

Frontiers in Public Health, 2023
IntroductionA period of exclusivity for the first generics, as part of the patent linkage system, was established in South Korea to provide an economic incentive for early generic entry.
Kyung-Bok Son
doaj   +1 more source

Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France. [PDF]

PLoS ONE, 2015
BACKGROUND:In the interest of cost effectiveness, switching antiretroviral brand name medications to generics is recommended in France since 2013. The study objective was to evaluate the perception of generics per se and antiretroviral generics in HIV ...
Christine Jacomet, Clotilde Allavena, Fleur Peyrol, Bruno Pereira, Laurence Morand Joubert, Haleh Bagheri, Laurent Cotte, Rodolphe Garaffo, Laurent Gerbaud, Pierre Dellamonica   +9 more
doaj   +1 more source

Clinical equivalence of generic and brand-name drugs used in cardiology: what do we know?

Consilium Medicum, 2021
The problem of using generics in the treatment of patients with cardiovascular diseases remains relevant for more than a decade. The concern of doctors, pharmacists and patients is not diminishing with the constant rise in cardiovascular morbidity and ...
Marina V. Leonova
doaj   +1 more source

Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo

Saudi Pharmaceutical Journal, 2023
Background: Epilepsy is a common global neurological disorder. About 30% of epileptic patients are managed with anti-epileptic Drugs (AEDs). Since 2000, Levetiracetam (LEV) has been marketed around the world as an AED under the brand name Keppra, and ...
Danah ALRabeeah, Aliyah Almomen, Nourah Alzoman, Maria Arafah   +3 more
doaj   +1 more source